bpc-157 cancer study Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation | Journal of Molecular Medicine Body Protecting Compound 157 (BPC-157

Common formulations include: BPC-157: 10 mg per vial in typical KLOW formulations TB-500: 10 mg per vial in typical KLOW formulations GHK-Cu: 50 mg per vial in typical KLOW formulations (highest proportion) KPV: 10 mg per vial in typical KLOW formulations Total blend: 80 mg combined peptide content Individual component research dosing: BPC-157 studies: 10 mcg/kg most common in rat models (range: 1-1000 mcg/kg) TB-500 studies: 1-10 mg/kg typical range in rodent research GHK-Cu studies: 0.01-100 nanomolar in cell culture

Can I take B12 injections every week

Huber, A

Research references 10 mcg/kg in animals, and human practice typically uses 200 to 800 mcg per day